Similar humoral responses but distinct CD4+ T cell transcriptomic profiles in older adults elicited by MF59 adjuvanted and high dose influenza vaccines

Huy Quang Quach,Iana H. Haralambieva,Krista M. Goergen,Diane E. Grill,Jun Chen,Inna G. Ovsyannikova,Gregory A. Poland,Richard B. Kennedy
DOI: https://doi.org/10.1038/s41598-024-75250-2
IF: 4.6
2024-10-18
Scientific Reports
Abstract:Older age (≥ 65 years) is associated with impaired responses to influenza vaccination, leading to the preferential recommendation of MF59-adjuvanted (MF59Flu) or high-dose (HDFlu) influenza vaccines for this age group in the United States. Herein, we characterized transcriptomic profiles of CD4 + T cells isolated from 234 recipients (≥ 65 years) of either MF59Flu or HDFlu vaccine, prior to vaccination and 28 days thereafter. We identified 412 and 645 differentially expressed genes (DEGs) in CD4 + T cells of older adults after receiving MF59Flu and HDFlu, respectively. DEGs in CD4 + T cells of MF59Flu recipients were enriched in 14 KEGG pathways, all of which were downregulated. DEGs in CD4 + T cells of HDFlu recipients were enriched in 11 upregulated pathways and 20 downregulated pathways. CD4 + T cells in both vaccine groups shared 50 upregulated genes and 75 downregulated genes, all of which were enriched in 7 KEGG pathways. The remaining 287 and 520 DEGs were specifically associated with MF59Flu and HDFlu, respectively. Unexpectedly, none of these DEGs was significantly correlated with influenza A/H3N2-specific HAI titers, suggesting these DEGs at the individual level may have a limited role in protection against influenza. Our findings emphasize the need for further investigation into other factors influencing immunity against influenza in older adults.
multidisciplinary sciences
What problem does this paper attempt to address?